Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. Our high purity 99% white powder offers superior efficacy for glucose control and weight loss studies compared to selective GLP-1 agonists.
Available in various packaging options from 2mg to 50mg vials, we provide flexible customization including private labeling. The compound demonstrates greater affinity for GIP receptors while effectively mimicking natural GIP action at the receptor level.
For research purposes only, our tirzepatide prices are highly competitive for bulk orders. The product undergoes strict quality control and third-party testing to ensure purity and consistency across batches.
Key advantages include: dual receptor agonist activity, superior glycemic control compared to single agonists, and significant weight reduction potential in preclinical studies.
